Delivery Order SPE2DB25D3404-SPE2DB25FUPAJ
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,657.14 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement of pharmaceutical inventory to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.64 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,612.16 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gadavist 7.5 mmol/7.5 ml vials. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a pediatric or diagnostic imaging pharmaceutical product supporting federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,704.90 by the Defense Logistics Agency on June 5, 2025, for the supply of Gadavist 1 mmol/ml bulk vial 30ml. The contract employs firm fixed price pricing and is not set-aside designated, indicating it was competitively awarded. Performance is scheduled for completion by June 6, 2025, with work to be performed at the contractor's Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $9,097.83 for Gadavist 10 mmol/10 ml vials from the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with a completion date of September 22, 2025. This firm fixed-price delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The contract has a firm fixed price of $1,704.90 and an ultimate completion date of March 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 10 mmol/10 ml vial (10 ml). The order has a ceiling value of $16,681.09 and is a firm fixed-price contract. The period of performance runs through September 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively,...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gadavist 10 MMOL/10 ML vials. The award, valued at $4,315.48, is a Firm Fixed Price Delivery Order with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency awarded a $1,711.35 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30ml GADAVIST 1 MMOL/ML bulk vial pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA Troop Support Medical...